Date:7/22/2009

rters Ended July 3, 2009 and June 27, 2008 (unaudited) (in thousands, except per share data) Quarter Ended Six Months Ended --------------- ------------------ July 3, June 27, July 3, June 27, 2009 2008 2009 2008 ---- ---- ---- ---- Revenues -------- Revenues before reimbursements $52,429 $50,801 $107,360 $102,823 Reimbursements 8,433 4,155 13,298 8,393 ----- ----- ------ ----- Revenues 60,862 54,956 120,658 111,216 ------ ------ ------- ------- Operating expenses ------------------ Compensation and related expenses 34,954 33,197 72,800 66,707 Other operating expenses 5,309 5,588 10,586 11,016 Reimbursable expenses 8,433 4,155 13,298 8,393 General and administrative expenses 3,227 3,207 5,859 6,196 ------ ------ ------- ------ 51,923 46,147 102,543 92,312 ------ ------ ------- ------ Operating income 8,939 8,809 18,115 18,904 Other income ------------- Interest income, net 200 463 434 965 Miscellaneous income, net 898 355 1,056 290 ---
'/>"/>

SOURCE Exponent, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Exponent to Announce Second Quarter 2009 Results
2. Exponent to Announce First Quarter 2009 Results
3. Europe Poised for Exponential Growth in the Digitised Medical Imaging Storage Space, Reveals Frost & Sullivan
4. Exponent to Announce Fourth Quarter and Fiscal Year 2008 Results
5. Exponent Reports Third Quarter 2008 Results
6. The Market for Disease-Modifying Osteoarthritis Drugs Will Experience Exponential Growth, Increasing From $477 Million in 2007 to Nearly $3.8 Billion in 2017
7. Exponent to Announce Second Quarter 2008 Results
8. Exponent Reports First Quarter 2008 Results
9. Exponent to Report First Quarter Fiscal 2008 Results
10. Exponent to Present at Sidoti and B. Riley Conferences
11. Exponent Reports Strong Third Quarter 2007 Results